Literature DB >> 6123366

Should every survivor of a heart attack be given a beta blocker? Part II. Evidence from a clinical pharmacological standpoint.

A Breckenridge.   

Abstract

Mesh:

Substances:

Year:  1982        PMID: 6123366      PMCID: PMC1499133          DOI: 10.1136/bmj.285.6334.37

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  15 in total

1.  Abrupt withdrawal of cardiovascular drugs.

Authors:  J G Gerber; A S Nies
Journal:  N Engl J Med       Date:  1979-11-29       Impact factor: 91.245

2.  The course of acute myocardial infarction. Feasibility of early discharge of the uncomplicated patient.

Authors:  J F McNeer; A G Wallace; G S Wagner; C F Starmer; R A Rosati
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

3.  Propranolol and impotence.

Authors:  R A Miller
Journal:  Ann Intern Med       Date:  1976-11       Impact factor: 25.391

4.  Letter: Impotence from propranolol?

Authors:  J W Knarr
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

5.  Propranolol in the therapy of angina pectoris.

Authors:  P M Gillam; B N Prichard
Journal:  Am J Cardiol       Date:  1966-09       Impact factor: 2.778

6.  Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.

Authors:  N S Baber; D W Evans; G Howitt; M Thomas; T Wilson; J A Lewis; P M Dawes; K Handler; R Tuson
Journal:  Br Heart J       Date:  1980-07

7.  Coronary artery syndromes after sudden propranolol withdrawal.

Authors:  E L Alderman; D J Coltart; G E Wettach; D C Harrison
Journal:  Ann Intern Med       Date:  1974-11       Impact factor: 25.391

8.  Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial.

Authors:  A Hjalmarson; D Elmfeldt; J Herlitz; S Holmberg; I Málek; G Nyberg; L Rydén; K Swedberg; A Vedin; F Waagstein; A Waldenström; J Waldenström; H Wedel; L Wilhelmsen; C Wilhelmsson
Journal:  Lancet       Date:  1981-10-17       Impact factor: 79.321

9.  Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.

Authors:  J L Day; N Simpson; J Metcalfe; R L Page
Journal:  Br Med J       Date:  1979-01-13

10.  Prognostic value of exercise testing soon after myocardial infarction.

Authors:  P Théroux; D D Waters; C Halphen; J C Debaisieux; H F Mizgala
Journal:  N Engl J Med       Date:  1979-08-16       Impact factor: 91.245

View more
  4 in total

Review 1.  The management of hypertension.

Authors:  B N Prichard; C W Owens
Journal:  Br J Clin Pharmacol       Date:  1986       Impact factor: 4.335

2.  Secondary prevention of myocardial infarction: an uncertain feeling.

Authors:  J T Hart; S L Barley
Journal:  J R Coll Gen Pract       Date:  1982-11

3.  Economic consequences of postinfarction prophylaxis with beta blockers: cost effectiveness of metoprolol.

Authors:  G Olsson; L A Levin; N Rehnqvist
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-07

4.  Exercise testing early after myocardial infarction: discussion paper.

Authors:  C E Handler
Journal:  J R Soc Med       Date:  1983-07       Impact factor: 18.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.